Men Are Injecting Peptides to Build Muscle and Recover Faster – But the Risks Are Real

Injectable peptides are licensed ‘for research use only’, but that doesn’t deter biohackers from selling them or gym goers from conducting their own experiments with unregulated vials ordered from the internet

‘Peptides have given me my life back,’ says Judd, a 52-year-old Texas resident with a broad Southern drawl, who’s speaking from the sailboat he now calls home.

The 30-year veteran of the fitness industry, who has coached dozens of world, national and state champions in bodybuilding, endurance sports, cycling and climbing, explains his experiments with peptides began after an accident in his former career as a crew boat captain. Following an accident at a refinery, Judd suffered mitochondrial damage, which caused life-threatening reactions whenever he came into contact with the common chemicals in products such as detergent, perfume or even food. ‘I could only eat two foods for about 15 years – two foods on the entire planet, no salt, no pepper, no nothing,’ he says.

It wasn’t until he discovered the peptide Thymosin Alpha-1 – a popular compound touted to regulate immune response – that he was able to find some respite from his symptoms. ‘Peptides helped me treat the chronic inflammation that was caused by my condition,’ he says.

Peptides are essentially short chains of amino acids linked together by peptide bonds. Insulin is a peptide, as is semaglutide, better known as Ozempic. But peptides are also used in the worlds of health and fitness to help people recover faster and improve performance. Back in the 80s and 90s, bodybuilders were notorious for experimenting with injectable peptide derivatives, and today they’re still being used for everything from faster injury recovery to improving energy levels and building muscle.

BPC-157 (Body Protection Compound-157) is a 15-amino-acid peptide, which is derived from a protein found in gastric juice. Preclinical studies, mostly taken from animal testing, suggest it may promote healing of muscles, tendons and bones by boosting blood vessel growth and reducing inflammation. It was when Judd began experimenting with BPC-157 that his unblemished report on peptides began to shift. ‘I can’t say enough good things about them,’ he says, ‘but there’s no such thing as a free lunch. I only took 60 micrograms for about nine days, and it triggered an autoimmune reaction. I’ve never had anything like that. I had my body attacking my own joints. It hurt so bad I couldn’t walk. It hurt to stand. My stomach was in cramps. I felt like I had anxiety. I felt like I was dying. [I later found] it causes anhedonia, which is where you just have that overwhelming sense of gloom and doom. I only took it for nine days, but the side-effects stayed with me for about 11 months.’

Despite their popularity, synthetic peptides like BPC-157 are not intended for human consumption, and selling or promoting them as supplements or to enhance performance is illegal. They’re also not approved by The Medicines and Healthcare products Regulatory Agency in the UK, and in the US they lack FDA approval. The World Anti-Doping Agency has banned their use in competitive sport. But this lack of regulation hasn’t deterred men like Judd, as well as amateur biohackers, from using them, promoting them and even selling them, which they do by using the disclaimer that these drugs are ‘for research purposes only’.

Online there has been a wave of different compounds gaining momentum, such as the ‘Wolverine Stack’, which is a combination of BPC-157 and TB-500 (Thymosin Beta-4 fragment).

Their popularity highlights a growing reality where injectable peptides are used despite sitting in a legal grey area, not to mention the potential risks they pose. Right now, bold claims are being made about their efficacy, and the drugs, which are alarmingly easy to procure, are being self-administered long before research has had the opportunity to catch up.

Beyond the Hype

While online influencers label peptides as biohacking healing tools, the scientific picture is far murkier. According to Flynn McGuire, a researcher in musculoskeletal medicine who recently led one of the most comprehensive reviews of the synthetic peptide BPC-157 to date, the public narrative is wildly out of sync with what has actually been proven. ‘Despite all the anecdotes online for how well this compound works, where’s the evidence for that? There’s very little,’ he says.

The researcher explains that at their simplest, ‘peptides are just long chains of amino acids or small proteins, which work in the body in a myriad of different ways.’ In theory, compounds like BPC-157 could act on several biological pathways linked to healing. ‘There’s an anti-inflammatory pathway that it works through,’ he says. ‘There’s an angiogenic pathway that it probably works through, and an antioxidant pathway that it probably works through.’

Angiogenesis, he explains, is ‘a fancy way of saying it grows new vessels’. It’s one of the key mechanisms often cited by fans of peptides. More blood flow to an injured area could, in theory, accelerate healing by delivering nutrients and increasing repair. But this is where the excitement runs ahead of the evidence. ‘There were three human studies,’ Dr McGuire says. ‘And with the musculoskeletal study, there was no control group. So, it’s hard to take anything from that other than: “that’s interesting, we should do a better study”.’

The overwhelming majority of research comes from rodent models, not humans. The doses used, the injection method, and even how the animals metabolise peptides differ significantly from how humans would. ‘A lot of what’s out there is preclinical,’ Dr McGuire says. ‘We don’t have long-term human data. We barely have short-term human data.’

There’s so little human data because peptides like BPC-157 have never gone through the standard formal drug development pipeline. No pharmaceutical company owns them, which means there’s little financial incentive to fund expensive trials. The existing research is almost entirely in rodents, with inconsistent methods that don’t meet regulatory standards. And because peptides are sold in a legal grey area as ‘research chemicals’, there’s no pharmaceutical grade version suitable for clinical testing. As a result, the science remains stuck in preclinical models while public interest accelerates at a rate far ahead of the actual evidence.

Meanwhile, the theoretical risks are anything but trivial. For example, because BPC-157 appears to stimulate new blood vessel growth, it may pose dangers for people with undiagnosed cancer or precancerous conditions. ‘Because of how angiogenic it is, there’s some very serious theoretical risk, especially for people with cancer,’ Dr McGuire says. ‘If you’re introducing something that allows neovascularisation (the biological process of forming new blood vessels), that could either cause it to grow or cause it to spread.’ When it comes to content online, these nuances rarely make it through. Polarising views with little nuance tend to get more traction. ‘No one gets online to say how bad something worked for them,’ Dr McGuire argues. ‘The reporting bias is so far in one direction.’

That’s what Judd experienced when he tried to sound the alarm about BPC-157. Discussing his experience of online peptide communities, he says, ‘I could post something as simple as, “I had a good experience with this peptide”, and I’d get dozens of comments and messages asking for help or advice.’ But when he questioned the safety of what was being shared, he was kicked out of a forum he was using. ‘People are terrified to post anything negative because they don’t want to be attacked or banned,’ he explains.

Compounding the issue is the regulatory vacuum peptides appear to sit in. ‘[The FDA has] said this is not something you can give to people,’ Dr McGuire says. Yet these restrictions are sidestepped with a simple disclaimer. ‘If something is sold as a research chemical, somehow it’s okay for anyone to buy it, which is crazy to me,’ he says. The loophole means anyone can order vials online, reconstitute the powder at home and inject themselves with no true guarantee of compound purity.

‘If the vial is not prepared correctly and it’s not sterile, there’s a real risk of infection’ warns Dr McGuire, and without proper dosing guidelines, controlled trial or medical oversight, every injection becomes an experiment where the user acts as the live test subject.

Stronger, Faster, Riskier

The risks Dr McGuire highlighted aren’t farfetched. Will Clarke, a strongman coach, explains how he’s watched peptides gain traction in the strongman community. ‘People message me asking about BPC-157, TB-500, all that stuff, and it’s always injury related,’ he says. ‘They want to get back to training faster, or they’ve seen someone online saying it healed their tendons overnight.’

What alarms him is how little caution many users in the gym show for injecting themselves. ‘I’ve had guys come to me and they’ve already ordered it,’ he says. ‘They don’t know how to dose it, they don’t know if it’s sterile, they don’t know where it’s come from. They’re just copying what a stranger on TikTok told them.

‘A lot of young lads want that quick fix. They think, “If I just jab this, I’ll be sorted”,’ he says. ‘But when you drill down into it, they haven’t done the boring stuff: proper rehab, proper loading, proper rest.’

Clarke’s thoughts are echoed by strength coach Shane Reece. One of the most established coaches in the strongman world, Reece has worked with everyone from 18x WSM competitor Mark Felix to Lucy Underdown, 2x Britain’s Strongest Woman. ‘The sport being extremely high risk, peptides are very popular within the scene,’ he says.

For years, peptides existed as an insider tool among elite strongmen hoping to manage injuries or speed up recovery. ‘BPC-157 was what I’d call an underground strength and conditioning drug,’ Reece says. ‘When an athlete gets injured, it was something that people would reach for,’ regardless of whether they competed in tested or untested federations. ‘It would be in a really small niche circuit, whereas now it is advertised and promoted, and companies are shouting about it, which I personally don’t agree with’.

Reece’s biggest concern is that peptides are increasingly used as a way to push through pain rather than properly address root causes. ‘You cannot use BPC without having a proper rehabilitation plan in place,’ he says. ‘All you’re going to do is reduce the inflammation, give yourself a sensation that the pain has gone, but the real issue hasn’t gone’. In his experience, this is where athletes hit a wall: the relief arrives first, and the injury worsens later. BPC-157 is no replacement for proper rehabilitation, he says.

Although animal research suggests tendon benefits, Reece’s decade of coaching has shown otherwise. ‘It doesn’t touch tendons in humans,’ he says. ‘Muscle belly (strains), I have seen very, very fast results with, but tendons, I’ve never seen it touch them.’ He says that people often self-diagnose, reach for BPC-157 and are surprised when their pain remains unchanged.

Reece doesn’t talk about peptides from merely an anecdotal standpoint. He has experimented with them himself, too. ‘I’ve used BPC probably 20 different times,’ he says. ‘The only time I’ve used it is if you require a date to be ready for something, that’s when I see that it is beneficial’. Even then, Reece admits it’s difficult to separate the peptide’s effect from everything else he’s doing in terms of rehab.

Similarly to Dr McGuire, what worries him most are the long-term unknowns. BPC-157 interacts with pathways involved in angiogenesis, nitric oxide signalling and cell growth which are the same mechanisms implicated in cancer biology. ‘These pathways could also affect cancer growth,’ he says. ‘We don’t know if it does or not, because it’s never been checked’. In his view, elite athletes using a compound for a short period are one thing, but the general population taking peptides daily for chronic pain is quite another. ‘You’ve got long term exposure to something, and you’re not even thinking about it’.

‘When I first started doing this, there was one company online,’ he says. ‘Now there are companies that sponsor athletes, it baffles me, how is it legal?’. As demand has grown, so have the risks. ‘Then you get more people trying to make money, underdosing or putting different stuff in the peptides, now you’re in a situation where I’m buying BPC, but you don’t even know if you’re getting BPC’.

What he didn’t expect was how far beyond strongman the trend would spread. After uploading one video about BPC-157, he suddenly found himself fielding questions from recreational lifters and even people with no athletic background at all. ‘I get all these people asking me stuff,’ he says. ‘I didn’t envision that at all. These are not the people who need it. It could be dangerous.’

Mass Appeal

Reece’s concerns echo what physicians are now seeing in clinics. Obesity specialist and certified physician Spencer Nadolsky says he has increasingly heard patients ask about BPC-157, despite there being no approved human product.

‘People think that BPC-157 is some magical angiogenic and tissue repair drug,’ he says, ‘but we don’t really have any good human data that it does that. So, I don’t think we should be injecting it’. For Dr Nadolsky, the biggest issue is that the version people are injecting isn’t a pharmaceutical. It’s an unregulated vial ordered from the internet. ‘You don’t even know what you’re getting,’ he says.

Like Dr McGuire and Reece, he warns that any compound affecting growth pathways carries a theoretical cancer risk. ‘If you’re doing something that might promote angiogenesis, could that promote tumour growth? It’s a theoretical risk that people just kind of brush off’. Even for injuries that seem straightforward, Nadolsky stresses that BPC-157 isn’t treating the cause, and may delay people from seeking proper medical assessment. ‘The risk is that you’re delaying actual care,’ he says. ‘You think, “Oh, I’ll just inject this stuff until it gets better”, and you might be missing something important.’

The purity issue is, in his view, the most immediate danger. ‘They say they’re selling BPC-157 but it could be underdosed, it could be overdosed, it could be something totally different.’ Unlike prescription peptides, which are manufactured under strict standards, research chemicals have no requirement for sterility or safety. ‘These vials can contain contaminants. If it’s not sterile and you’re injecting it, you could get an abscess or systemic infection,’ he warns.

‘The stuff has exploded. It’s everywhere. It’s just the Wild West,’ he says. And again, he says the biggest users aren’t people who you might expect. ‘It’s not just hardcore lifters, it’s regular people who saw it on TikTok’. Patients arrive convinced it’s a silver bullet for everything from tendon pain to gut issues, yet the conversation always comes back to the same point: ‘There’s no human clinical data. Nothing,’ he says.

Promise, Not Proof

‘I’m open to the idea that maybe someday we’ll find a benefit,’ Dr Nadolsky says, ‘but right now? The claims are outrageous.’

Taken together, the picture is becoming clear that everyday lifters, athletes and even young people are experimenting with substances that haven’t been approved for human use – influenced by online anecdotes rather than real evidence. The appeal is obvious: faster healing and more energy, which means more time in the gym, but the reality is far more uncertain. Even the idea that they could increase the rate of muscle gain is vastly undersupported by science. And it’s clear that each injection is a risky experiment, with unknown purity, unknown dosing and unknown long-term effects.

Experts who work in elite sport, like Reece, or in medical practice, like doctors Nadolsky and McGuire, agree on the same point that the science is nowhere near ready for the way peptides are currently being used. The loophole that allows them to be sold for research use only lets anyone order a substance potent enough to influence biological pathways linked to inflammation, angiogenesis and cell growth, without any guarantee of what’s actually inside the vial.

For now, the safest approach is still the most boring: proper rehab, gradual loading, sleep, nutrition and medical guidance when injuries don’t improve. Peptides may one day prove to have legitimate clinical applications. But until the research catches up, and regulation does, too, the risks belong entirely to the user and those risks are not completely theoretical.

Here’s your starter guide to peptides in the health and fitness space, their purported benefits and what the science says…

Peptide name: BPC-157

Usage: Marketed for tendon and ligament healing, gut health and rapid recovery between workouts.

What the science currently says: Evidence comes almost entirely from rodent studies, only a handful of low-quality human reports currently exist and it’s not an approved human drug. Concerns include theoretical cancer risks and inconsistent quality in research chemical products.

Peptide name: TB-500

Usage: For soft tissue healing and improved mobility, often paired with BPC-157 and called the ‘Wolverine Stack’.

What the science currently says: Animal studies suggest thymosin beta-4 could aid tissue repair, but there are no robust human trials for sports injuries or recovery. Research chemical TB-500 products vary widely in purity and dose and online recommendations are based on anecdotes, not actual clinical data.

Peptide name: Thymosin Alpha-1

Usage: Used medically in some countries, adopted online for inflammation and immune support.

What the science currently says: Pharmaceutical-grade Thymosin Alpha-1 exists for specific clinical conditions, but the versions sold online are completely unregulated. No evidence supports general wellness use, and long-term safety data in healthy people is lacking.

Peptide name: CJC-1295 / Ipamorelin

Usage: Marketed for muscle gain, fat loss, improved sleep and anti-ageing via increased growth hormone.

What the science currently says: Limited human research. Growth hormone manipulation carries real risks, including insulin resistance, swelling and theoretical cancer concerns. Online products are unregulated and often mislabelled.

Peptide name: GHK-Cu

Usage: Popular in skincare and regenerative medicine, promoted for improving skin elasticity and wound healing. Sometimes used by biohackers who purport anti-ageing or recovery benefits.

What the science currently says: Human research shows GHK-Cu can influence collagen production and wound healing topically, but evidence for injectable use is minimal. Most claims come from cell studies, not clinical trials.